Robert W. Fairbairn, Director at BlackRock Capital Allocation Trust (BCAT), bought 64,282 shares at $22.97 ($1.5M) on 2020-12-21, disclosed to the SEC on 2021-11-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.98 | 21,141 | $486K | 32.9% |
| 2 | $22.98 | 21,141 | $486K | 32.9% |
| 3 | $22.97 | 22,000 | $505K | 34.2% |
| Total | $22.98 avg | 64,282 | $1.5M | 100% |
| Filing → |
| BSTZ | SELL | 2025-12-22 | $418K | — | Filing → |
| BTX | SELL | 2025-12-22 | $286K | — | Filing → |
| ECAT | BUY | 2022-05-13 | $1.2M | — | Filing → |